Emergent BioSolutions

+$0.22 (+0.48%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EBS and other ETFs, options, and stocks.

About EBS

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats.

CEO

Robert G. Kramer

Employees

2,200

Headquarters

Gaithersburg, Maryland

Founded

1998

EBS Key Statistics

Market cap

Price-Earnings ratio

11.06

Dividend yield

—

Average volume

625.71K

High today

$47.01

Low today

$44.58

Open price

$45.26

Volume

415.59K

52 Week high

$127.20

52 Week low

$29.88

EBS News

Simply Wall StJan 20

Does Emergent BioSolutions Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky

Analyst ratings

Buy

42.9%

Hold

57.1%

Sell

EBS Earnings

-$0.36

$0.98

$2.33

$3.67

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Feb 17, Pre-Market

Why Robinhood?

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. View more

Does Emergent BioSolutions Have A Healthy Balance Sheet?

57%

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats.